Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-22-019118
Filing Date
2022-07-19
Accepted
2022-07-19 17:34:06
Documents
1
Period of Report
2022-07-18

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165826643238528.html 3  
1 FORM 3 wf-form3_165826643238528.xml 3 1702
  Complete submission text file 0001628280-22-019118.txt   3060
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Issuer) CIK: 0001600620 (see all company filings)

EIN.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address SOVEREIGN HOUSE, VISION PARK, HISTON CAMBRIDGE X0 CB249BZ
Business Address
Knappertz Volker (Reporting) CIK: 0001754122 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36421 | Film No.: 221092331